Jordi Canes

Scientific Manager Head

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (7)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Manel Juan

Head of Immunology service/department

Hospital Clínic de Barcelona

SPAIN

View details

Montserrat Muñoz Mateu

Professora associada

University of Barcelona

SPAIN

View details

Ana Arance

University of Barcelona

SPAIN

View details

Mireia Margeli Vila

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Xavier Gonzàlez Farré

Associate professor

Universitat Internacional de Catalunya

SPAIN

View details

ENRIQUETA FELIP

Head Thoracic Oncology Unit (After Competitive Exam)

Hospital Universitari Vall d'Hebron

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jordi Canes

Research Interests

Explore related searches

Contact this professor

Articles (7)

HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer

SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of <i>PD1</i> mRNA

Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?

Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study

SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer.

Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial

Collaborators (6)

Manel Juan

Montserrat Muñoz Mateu

Ana Arance

Mireia Margeli Vila

Xavier Gonzàlez Farré

ENRIQUETA FELIP

Make your next move.